ITRM20130223A1 - CODEINE DERIVATIVES AS INHIBITORS OF MORUCINE GLUCURONATION - Google Patents

CODEINE DERIVATIVES AS INHIBITORS OF MORUCINE GLUCURONATION

Info

Publication number
ITRM20130223A1
ITRM20130223A1 IT000223A ITRM20130223A ITRM20130223A1 IT RM20130223 A1 ITRM20130223 A1 IT RM20130223A1 IT 000223 A IT000223 A IT 000223A IT RM20130223 A ITRM20130223 A IT RM20130223A IT RM20130223 A1 ITRM20130223 A1 IT RM20130223A1
Authority
IT
Italy
Prior art keywords
morucine
glucuronation
inhibitors
codeine derivatives
codeine
Prior art date
Application number
IT000223A
Other languages
Italian (it)
Inventor
Letizia Antonilli
Armandodoriano Bianco
Laura Guarcini
Paolo Nencini
Rosario Nicoletti
Anna Rita Togna
Giuseppina Ines Togna
Alessandro Venditti
Original Assignee
Rosario Nicoletti
Univ Roma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosario Nicoletti, Univ Roma filed Critical Rosario Nicoletti
Priority to IT000223A priority Critical patent/ITRM20130223A1/en
Publication of ITRM20130223A1 publication Critical patent/ITRM20130223A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
IT000223A 2013-04-15 2013-04-15 CODEINE DERIVATIVES AS INHIBITORS OF MORUCINE GLUCURONATION ITRM20130223A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT000223A ITRM20130223A1 (en) 2013-04-15 2013-04-15 CODEINE DERIVATIVES AS INHIBITORS OF MORUCINE GLUCURONATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000223A ITRM20130223A1 (en) 2013-04-15 2013-04-15 CODEINE DERIVATIVES AS INHIBITORS OF MORUCINE GLUCURONATION

Publications (1)

Publication Number Publication Date
ITRM20130223A1 true ITRM20130223A1 (en) 2014-10-16

Family

ID=48446520

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000223A ITRM20130223A1 (en) 2013-04-15 2013-04-15 CODEINE DERIVATIVES AS INHIBITORS OF MORUCINE GLUCURONATION

Country Status (1)

Country Link
IT (1) ITRM20130223A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB751994A (en) * 1953-03-30 1956-07-04 Rech S Biolog Laborec Lab De New derivatives of alkaloids
US5977395A (en) * 1994-05-27 1999-11-02 Rhone-Poulenc Chimie Ester syntheses and transesterifiable xanthate reactants therefor
WO1999058545A1 (en) * 1998-05-13 1999-11-18 Cenes Limited Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides
WO2002016367A1 (en) * 2000-08-25 2002-02-28 Glaxo Wellcome Australia Ltd Chemical methods
WO2007120864A2 (en) * 2006-04-14 2007-10-25 Shire Llc Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
WO2011011543A1 (en) * 2009-07-21 2011-01-27 Nektar Therapeutics Oligomer-opioid agonist conjugates
WO2011088140A1 (en) * 2010-01-12 2011-07-21 Nektar Therapeutics Pegylated opioids with low potential for abuse and side effects

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB751994A (en) * 1953-03-30 1956-07-04 Rech S Biolog Laborec Lab De New derivatives of alkaloids
US5977395A (en) * 1994-05-27 1999-11-02 Rhone-Poulenc Chimie Ester syntheses and transesterifiable xanthate reactants therefor
WO1999058545A1 (en) * 1998-05-13 1999-11-18 Cenes Limited Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides
WO2002016367A1 (en) * 2000-08-25 2002-02-28 Glaxo Wellcome Australia Ltd Chemical methods
WO2007120864A2 (en) * 2006-04-14 2007-10-25 Shire Llc Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
WO2011011543A1 (en) * 2009-07-21 2011-01-27 Nektar Therapeutics Oligomer-opioid agonist conjugates
WO2011088140A1 (en) * 2010-01-12 2011-07-21 Nektar Therapeutics Pegylated opioids with low potential for abuse and side effects

Similar Documents

Publication Publication Date Title
IL279682A (en) Benzoquinolone inhibitors of vmat2
DK3080100T3 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETHYLASE-1
DK3527263T3 (en) BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS
AR095266A1 (en) TETRACICLIC BROMODOMINES INHIBITORS
DK3290407T3 (en) Bromodomain inhibitors
DK3010503T3 (en) New bicyclic bromodomain inhibitors
DK3527563T3 (en) DNA-PK INHIBITORS
FR3009588B1 (en) MOBILE AUB OF TURBOMACHINE
DK3068776T3 (en) INHIBITORS OF REPLICATION OF INFLUENZAVIRA
AR092198A1 (en) DERIVATIVES OF PIRAZOLOPIRIMIDINAS
SMT201500208B (en) Piridinone derivatives as inhibitors of tissue transglutaminase
HRP20181710T1 (en) Use of benzimidazole-proline derivatives
DK2970235T3 (en) NEW INHIBITORS
BR112016007757A2 (en) antibacterial derivatives of 2h-indazole
DK2952513T3 (en) AZOLBENZENDER DERIVATIVE
HK1222339A1 (en) Inhibitors of metallo-ss-lactamase-enzymes --
HK1221645A1 (en) Benzoquinolone inhibitors of vmat2 vmat2
IL240763A0 (en) Halogenopyrazoles as inhibitors of therombin
ITRM20130223A1 (en) CODEINE DERIVATIVES AS INHIBITORS OF MORUCINE GLUCURONATION
FR2997080B1 (en) INHIBITORS OF NEPRILYSINE
DK3041825T3 (en) METHOD OF SYNTHESIS OF N-BENZYL-N-CYCLOPROPYL-1H-PYRAZOL-4-CARBOXAMIDE DERIVATIVES
ES1098808Y (en) TOY-INSTRUMENT OF MUNECO BAILARIN
TH1501001602A (en) New bicyclic derivatives
UA28440S (en) SET OF LABELS
UA27116S (en) SET OF DIRECT FOR FURNITURE